A phase I/II trial of pemetrexed plus radiotherapy in elderly patients with locally advanced non-small cell lung cancer

Conclusions Combination PEM and RT shows promising efficacy but relatively severe RT-related toxicities. Therefore, this treatment should be prescribed to elderly patients with caution.Trial registration UMIN 000005036.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research